谢立平 - 浙江大学

个人简介

2007年5月美国哈佛大学医学院泌尿外科学习。学习内容：泌尿肿瘤 2004年9月美国约翰霍普金斯大学泌尿外科研究所学习。学习内容：前列腺癌 2004年5月美国南加州大学Norris肿瘤中心学习。学习内容：膀胱癌和前列腺癌 2001年4月-2001年7月美国西弗吉尼亚大学医学院泌尿外科学习。研究方向：膀胱肿瘤治疗 1991年1月-1993年10月德国基尔大学医学院，获医学博士学位。研究方向：肾功能保护 1985年9月-1988年6月浙江医科大学硕士学位。研究方向：前列腺增生 1978年3月-1982年12月浙江医科大学临床医学系本科。

研究领域

主要研究领域为泌尿系肿瘤、泌尿微创外科及前列腺疾病。近年来，作为主要负责人参与基因工程制药，腹腔镜器械研发，医学可视化技术等工作。

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1. Li Y, Yang K, Mao Q, Zheng X, Kong D, Xie L*. Inhibition of TGF-beta receptor I by siRNA suppresses the motility and invasiveness of T24 bladder cancer cells via modulation of integrins and matrix metalloproteinase. Int Urol Nephrol. 2009 Aug 8. [Epub ahead of print] 2. Mao Q, Zheng X, Jia X, Wang Y, Qin J, Yang K, Bai Y, Xie L*. Relationships between total/free prostate-specific antigen and prostate volume in Chinese men with biopsy-proven benign prostatic hyperplasia. Int Urol Nephrol. 2009 Feb 18. [Epub ahead of print]. 3. Yan TZ, Jin FS, Xie LP, Li LC. Relationship between Glucocorticoid Receptor Signal Pathway and Androgen-Independent Prostate Cancer. Urol Int. 2008; 81: 228-233. 4. Mao QQ, Li YB, Zheng XY, Yang K, Shen HF, Qin J, Bai Y, Kong DB, Jia XL, Xie LP*. Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells. Biochem Biophys Res Commun. 2008, 375(4): 566-570. 5. Jiang J, Zheng X, Qin J, Zheng M, Mao Q, Zhang Z, Cai S, Xie L*. Health-related quality of life after hand-assisted laparoscopic and open radical nephrectomies of renal cell carcinoma. Int Urol Nephrol. 2009; 41(1):23-7. 6. Zheng XY, Xie LP*, Wang YY, Ding W, Yang K, Shen HF, Qin J, Bai Y, Chen ZD.The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4-10 ng/mL.J Cancer Res Clin Oncol. 2008 Nov; 134(11): 1207-10. 7. Yang K, Zheng XY, Qin J, Wang YB, Bai Y, Mao QQ, Wan Q, Wu ZM, Xie LP*. Up-regulation of p21 (WAF1/Cip1) by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cells. Cancer Lett. 2008 Jul 8; 265(2): 206-214. 8. Zheng X, Xie L*, Qin J, Shen H, Chen Z, Jin Y. Effects of wortmannin on phosphorylation of PDK1, GSK3-beta, PTEN and expression of Skp2 mRNA after ischemia/reperfusion injury in the mouse kidney. Int Urol Nephrol. 2008; 40(1): 185-92. 9. Xie LP*, Bai Y, Zhang XZ, Zheng XY, Yao KS, Xu L, Zeegers M. Obesity and Benign Prostatic Enlargement: A Large Observational Study in China. Urology, 2007, 69(4): 680-684. 10. Qin J, Xie LP*, Zheng X, Wang Y, Bai Y, Shen H, Li LC, Dahiya R.A component of Green Tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochemical and Biophysical Research Communications, 2007, 354(4): 852-857. 11. Xie LP, Zheng XY, Qin J, Chen ZD, Jin YF, Ding W. Role of PI3-kinase/Akt signaling pathway in renal function and cell proliferation after renal ischemia/reperfusion injury in mice. Nephrology, 2006, 11(3): 207-212. 12. Xie LP*, Qin J, Zheng XY, Chen ZD. Undescended epididymo-testicular metastasis from prostatic carcinoma. Asian Journal of Andrology, 2006, 8 (2): 251-252. 13. Jian L, Xie LP, Lee AH, et al. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer. 2004, 108(1): 130-135.